Precision BioSciences, Inc.
DTIL
$4.89
$0.102.09%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -99.07% | -98.56% | -11.11% | 40.98% | 43.62% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -99.07% | -98.56% | -11.11% | 40.98% | 43.62% |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -99.07% | -98.56% | -11.11% | 40.98% | 43.62% |
| SG&A Expenses | 1.28% | 3.68% | -1.08% | -8.16% | -18.74% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -1.21% | -3.75% | 3.40% | 2.59% | -2.08% |
| Operating Income | -452.28% | -1,135.40% | -27.53% | 40.18% | 60.43% |
| Income Before Tax | -828.37% | -595.50% | -9.99% | 116.85% | 123.66% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -828.37% | -595.50% | -9.99% | 116.85% | 123.66% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | 88.58% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1,069.52% | -561.16% | 20.54% | 111.69% | 111.73% |
| EBIT | -452.28% | -1,135.40% | -27.53% | 40.18% | 60.43% |
| EBITDA | -634.12% | -3,981.85% | -45.06% | 38.36% | 64.20% |
| EPS Basic | -10,630.08% | -3,944.18% | 73.88% | 112.00% | 100.41% |
| Normalized Basic EPS | -1,731.74% | -2,130.45% | 67.42% | 118.29% | 105.20% |
| EPS Diluted | -16,420.39% | -4,486.42% | 73.46% | 111.80% | 100.26% |
| Normalized Diluted EPS | -1,838.95% | -1,966.04% | 66.91% | 118.01% | 104.88% |
| Average Basic Shares Outstanding | 73.41% | 80.76% | 90.67% | 79.78% | 53.86% |
| Average Diluted Shares Outstanding | 73.06% | 80.33% | 90.91% | 80.09% | 54.17% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |